Hepatitis D MRI: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatitis D}} | {{Hepatitis D}} | ||
{{CMG}}; {{AOEIC}} {{VK}} | {{CMG}}; {{AOEIC}} {{VK}}; {{JS}} {{JM}} | ||
==Overview== | ==Overview== | ||
The [[MRI]] may be used to diagnose/monitor [[biliary]] obstruction, [[cirrhosis]], and [[hepatocellular carcinoma]] in hepatitis D | The [[MRI]] may be used to diagnose/monitor [[biliary]] obstruction, [[cirrhosis]], and [[hepatocellular carcinoma]] in patients with [[hepatitis D]]. [[MRI]] findings in these patients may include: nodular appearance of the liver and signs of [[portal hypertension]], such as [[ascites]] and [[splenomegaly]]. | ||
==MRI== | ==MRI== | ||
In patients with hepatitis D, an [[MRI]] may be performed to: | In patients with hepatitis D, an [[MRI]] may be performed to:<ref name="pmid18333158">{{cite journal| author=Bialecki ES, Di Bisceglie AM| title=Diagnosis of hepatocellular carcinoma. | journal=HPB (Oxford) | year= 2005 | volume= 7 | issue= 1 | pages= 26-34 | pmid=18333158 | doi=10.1080/13651820410024049 | pmc=PMC2023919 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18333158 }} </ref> | ||
*Exclude [[biliary]] obstruction | *Exclude [[biliary]] obstruction | ||
*Diagnose/monitor [[hepatic cirrhosis]] and [[hepatocellular carcinoma]] | *Diagnose/monitor [[hepatic cirrhosis]] and [[hepatocellular carcinoma]] | ||
The [[MRI]] findings in patients with [[hepatic cirrhosis]] may include: a shrunken [[liver]] with nodular appearance, and signs of [[portal hypertension]], such as [[splenomegaly]] and [[ascites]]. | The [[MRI]] findings in patients with [[hepatic cirrhosis]] may include: a shrunken [[liver]] with nodular appearance, and signs of [[portal hypertension]], such as [[splenomegaly]] and [[ascites]]. | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Hepatitis|D]] | [[Category:Hepatitis|D]] | ||
[[Category:Viruses]] | [[Category:Viruses]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hepatology]] | |||
Latest revision as of 22:06, 29 July 2020
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D MRI On the Web |
|
American Roentgen Ray Society Images of Hepatitis D MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
The MRI may be used to diagnose/monitor biliary obstruction, cirrhosis, and hepatocellular carcinoma in patients with hepatitis D. MRI findings in these patients may include: nodular appearance of the liver and signs of portal hypertension, such as ascites and splenomegaly.
MRI
In patients with hepatitis D, an MRI may be performed to:[1]
- Exclude biliary obstruction
- Diagnose/monitor hepatic cirrhosis and hepatocellular carcinoma
The MRI findings in patients with hepatic cirrhosis may include: a shrunken liver with nodular appearance, and signs of portal hypertension, such as splenomegaly and ascites.
References
- ↑ Bialecki ES, Di Bisceglie AM (2005). "Diagnosis of hepatocellular carcinoma". HPB (Oxford). 7 (1): 26–34. doi:10.1080/13651820410024049. PMC 2023919. PMID 18333158.